James Cancer Hospital
|James Cancer Hospital|
|Location||Columbus, Ohio, USA|
|Affiliated university||The Ohio State University|
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (commonly shortened to just James Cancer Hospital, officially abbreviated OSUCCC - James, and colloquially referred to as The James) is part of Ohio State University, one of the nation’s largest public universities. The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.
It is named after Arthur G. James, the founder, who desired a free-standing cancer hospital in Columbus, Ohio, United States.
As the Midwest's first and Ohio's only fully dedicated cancer hospital and research institute, The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC–James) is one of the nation's premier cancer centers for the prevention, detection and treatment of cancer.
The OSUCCC–James is one of only 41 centers in the United States designated by the National Cancer Institute a Comprehensive Cancer Center. In addition, the OSUCCC–James is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers that develops clinical practice guidelines to improve the quality and effectiveness of care provided to patients with cancer.
The OSUCCC–James is the only cancer program in the country that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nation's largest public universities.
The cancer program at Ohio State encompasses nearly 300 comprehensive cancer center members from 11 of the 14 colleges at Ohio State University. The OSUCCC–James' singular focus on cancer has led to multiple accomplishments that have changed the standards of care with respect to prevention, diagnosis and treatment, in a way that substantially improves outcomes for cancer patients.
In 2009, Ohio State University Board of Trustees approved a $1 billion expansion of the cancer hospital and Medical Center facilities, including a new 276-bed* cancer hospital and critical care building. This expansion sets Ohio State apart as a national leader in innovative cancer care by supporting new, high-quality, patient-centered, personalized medicine. The new hospital will have increased capacity to help keep pace with the projected 21 percent growth in admissions during the next decade.
The new James Cancer Hospital and Solove Research Institute will expand access to world-class cancer care in central Ohio, helping to meet a projected 21-percent increase in patient admissions over the next 10 years.
With a $100 million grant from the U.S. Department of Health and Human Services’ Health Resources and Services Administration, they have developed one of very few above-ground radiation oncology units in the country, offering patients natural light and outside views during their treatment.
The hospital’s design combines research and education spaces on every patient care floor, which will accelerate the creation of new diagnostic tools and treatments.
It will also serve as one of the largest classrooms in the state, with healthcare education spaces on every patient floor that will be used by students, residents and fellows, and faculty and staff teams for collaboration and continuing education.
The new James Cancer Hospital and Solove Research Institute features fully equipped rooms that allow patients to receive nearly all of their care in the comfort of their own rooms.
Every patient suite in the new Critical Care Center includes adjoining areas where loved ones can stay, sleep and shower, keeping families together.
Patient friendly concourses and inviting lobbies link laboratories, classrooms, offices and garages, giving patients and visitors convenient access to all of the Medical Center’s healthcare services.
Ohio State’s electronic medical record system will be accessible in every room involved in patient care, giving your care team immediate access to your medical records and ensuring safe, accurate coordinated care.
JCAHO The James Cancer Hospital and Solove Research Institute is accredited by The Joint Commission, an independent, not-for-profit organization that evaluates the quality and safety of care provided by healthcare organizations across the nation. In December 2008, The James completed another successful survey and was fully accredited for three years.
The American College of Surgeons Commission on Cancer The James Cancer Hospital is accredited by The American College of Surgeons Commission on Cancer (CoC). The CoC accredits cancer programs based on a comprehensive evaluation of: institutional and programmatic resources; program management and administration; clinical management; inpatient and outpatient care; supportive care services; research; quality management and improvement; cancer-data management; public education, prevention and detection; and professional education and staff support.
Foundation for the Accreditation of Cellular Therapy (FACT) The James’ Blood and Marrow Transplant (BMT) program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). FACT accredited the BMT program for allogeneic and autologous transplantation, including clinical, collection (apheresis and perioperative services for bone marrow harvest), and processing. FACT accreditation attests to the high quality of The James’ BMT program.
Clinical Trials 
The James is one of only seven centers in the country funded by the National Cancer Institute to conduct both phase I and phase II clinical trials for new anti-cancer drugs. The resulting benefit to patients is that they have access to some of the most advanced cancer treatments and clinical trials offered anywhere in the world. When you participate in a clinical trial, you receive the same excellent cancer care you would normally receive. In addition, you have access to new treatments that are only available through the clinical trial. A clinical trial may involve the collection of cancer tissue and fluids, while others test new drugs or combinations of drugs and still others evaluate new approaches to preventing cancer.
Since 1976, the Ohio State University Comprehensive Cancer Center has been one of 41 NCI-designated comprehensive cancer centers in the nation.
A Comprehensive Cancer Center (CCC) must demonstrate reasonable depth and breadth of research activities in each of three major areas: laboratory, clinical and population-based research, with substantial trans-disciplinary research that bridges these scientific areas. An NCI-designated Comprehensive Cancer Center must also demonstrate professional and public education and dissemination of clinical and public health advances into the community it serves.
In its 2010 renewal review, Ohio State’s Comprehensive Cancer Center received the NCI’s highest possible rating as "EXCEPTIONAL". In its review, the NCI stated that the James "should serve as the model for other matrix university-based Centers".